Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1835 studies found for:    "Ovarian Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Ovarian Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Biobehavioral Influences and the Ovarian Tumor Microenvironment
Condition: Ovarian Neoplasms
Intervention:
2 Completed ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Sagopilone (ZK 219477) + carboplatin
3 Active, not recruiting [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel
4 Completed
Has Results
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: bevacizumab;   Drug: erlotinib
5 Terminated Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: IP chemotherapy
6 Completed Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Condition: Ovarian Neoplasms
Intervention: Procedure: removal of ovarian vessels
7 Completed A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
Condition: Ovarian Neoplasm
Intervention:
8 Completed Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
9 Completed DOXIL for Consolidation Therapy in Ovarian Cancer.
Condition: Ovarian Neoplasm
Intervention: Drug: liposomal doxorubicin
10 Recruiting Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Condition: Ovarian Neoplasms
Interventions: Procedure: Pelvic imaging;   Procedure: Blood draw;   Procedure: laparotomy or laparoscopy
11 Active, not recruiting Lymphadenectomy In Ovarian Neoplasms
Condition: Ovarian Cancer
Interventions: Procedure: No Lymphadenectomy (LNE);   Procedure: Lymphadenectomy (LNE)
12 Active, not recruiting
Has Results
Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: AZD2281;   Drug: Liposomal Doxorubicin
13 Completed A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
Condition: Ovarian Neoplasm
Interventions: Drug: Cyclophosphamide;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: G-CSF
14 Completed
Has Results
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Ovarian Cancer
Interventions: Drug: AZD0530;   Drug: Carboplatin;   Drug: Paclitaxel
15 Active, not recruiting
Has Results
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: KU-0059436 (AZD2281)(PARP inhibitor)
16 Completed Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
Condition: Ovarian Neoplasms
Intervention: Drug: Carboplatin plus Celecoxib
17 Recruiting KOrean Borderline Ovarian Tumor (KOBOT) Registry
Condition: Ovarian Neoplasms
Intervention:
18 Completed MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
Condition: Ovarian Neoplasms
Intervention: Radiation: MR-PET
19 Recruiting Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
Condition: Ovarian Neoplasms
Intervention: Procedure: Abnormal Ovarian Ultrasound
20 Completed TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: TLK286

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.